Elite Pharmaceuticals, Inc. (ELTP) News
Track canonical SquawkNews coverage tagged to ELTP, Elite Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about otc markets otcqb, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript
Elite Pharmaceuticals (OTC: ELTP ) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and
EARNINGS | Jul 02, 2026, 11:57 AM UTC
H
Elite Pharmaceuticals Q4 EPS $0.01 Down From $0.02 YoY, Sales $40.748M Up From $31.996M YoY
Elite Pharmaceuticals (OTC: ELTP ) reported quarterly earnings of $0.01 per share. This is a 50 percent decrease over earnings of $0.02 per share from the same period last year. The company reported $40.748 million in sa
EARNINGS | Jun 29, 2026, 09:11 PM UTC